Emergency Operations Plan for Pandemic Influenza

Objectives

Nauru’s pandemic influenza plan provides a national framework for government, corporations and non-governmental organisations to prepare for, mitigate and respond to an influenza pandemic. It applies the 2005 World Health Organization phase framework across inter-pandemic, pandemic-alert, pandemic and post-pandemic periods, with actions differentiated by pandemic phase and by whether cases are occurring locally.[1][2][3]

• Strengthen surveillance through notification of influenza-like illness, case investigation, laboratory confirmation, absenteeism monitoring and reporting of unusual bird, poultry and swine deaths.[4]
• Reduce transmission through quarantine, traveller and vessel controls, isolation and cohorting of patients, infection-control precautions, restrictions on selected hospital admissions, institutional closures where necessary, and advice for affected contacts to remain mostly at home.[3][5][6]
• Protect health workers, first responders and essential-service personnel, who face substantial exposure risk and may be prioritised for the limited available antiviral treatment and any future pandemic vaccine.[7][8]
• Secure and distribute vaccines, antivirals, antibiotics and infection-control supplies, while recognising that pandemic-specific vaccine may initially be unavailable or insufficient for the population and that other preventive and therapeutic supplies may be constrained.[7][4][9][8]
• Maintain essential services and expand health-system capacity by mobilising additional personnel, identifying supplementary treatment facilities and equipment, and planning for service disruption caused by illness-related staff shortages.[7][9]
• Communicate symptoms, preventive measures and response information to the public, including addressing unreliable or false information as pandemic conditions and community impacts change.[3][10]
• Coordinate internationally on surveillance, information exchange, procurement support, vaccine availability, research, adaptable guidance, travel alerts and faster vaccine supply.[3]

The plan is designed for a scenario in which influenza may reach Pacific countries rapidly, cause severe illness and deaths among vulnerable people, overload health services, and disrupt essential community functions. It anticipates that an initial pandemic wave could last one to three months and that the overall pandemic period could extend for two to three years.[7]

Implementation

Implementation is led through the Nauru Pandemic Influenza Task Force, developed in consultation with the World Health Organization and chaired by the Director of Public Health. The Task Force brings together health services, immigration, aviation, police, ports, quarantine, laboratory services and non-state representatives, may expand its membership when needed, and reports meeting outcomes through its chair to the Minister for Health.[1][6]

• Coordinate preparedness across public and private-sector partners, government authorities, health workers, first responders, essential-service providers and neighbouring countries sharing air and shipping links.[1][7][3]
• Convene the Task Force monthly during lower phases, more frequently when required, and at least weekly during Phase 6.[10]
• Develop phase-specific response-plan components, reporting systems, case-investigation protocols, data systems and local exercises, with responsibilities assigned to named authorities according to pandemic phase and local case status.[3][10][4]
• Operate surveillance through hospital and community detection of influenza-like illness, interviews to identify potential exposure sources, monthly absenteeism reporting in phases 4 to 6, weekly absenteeism reporting in Phase 6, and monitoring of animal die-offs.[4]
• Confirm suspected outbreaks using rapid tests and selected specimens sent to a level-2 reference laboratory for virus isolation, confirmation and strain subtyping; arrange specimen-shipment funding and identify suitable laboratories.[4]
• Apply border and community controls through quarantine officers, police, Immigration, Air Nauru and public-health personnel, including vessel and traveller quarantine, designated quarantine facilities, and legal authority for travel restrictions and sick leave.[5]
• Deliver clinical and infection-control measures through hospital clinicians, laboratory staff, health inspectors, community health nurses and other health personnel, including patient isolation, household monitoring, hand and respiratory hygiene, personal protective equipment where appropriate, visitor restrictions and removal of symptomatic health workers from direct care where possible.[6][8]
• Use additional facilities when needed, including the identified International Organisation for Migration camp isolation facility, and seek agreements for supplementary premises, mattresses, staffing, medicines and supplies.[9][6]
• Procure or seek external support for antivirals, antibiotics, vaccines and other supplies, including through the World Health Organization and foreign aid; 200 courses of oseltamivir are identified for priority services, although further procurement and specimen-shipment costs may require external support.[4][9][8]
• Exchange information electronically, by telephone and through meetings with the World Health Organization, the Pacific Public Health Surveillance Network, PACNET, ProMED and other countries.[10]

Governance includes annual review by the Task Force and a debrief after escalation to Phase 5 or above, assessing operational effectiveness and social, economic and health effects before updating the plan. The available material identifies surveillance and phase-linked responsibilities but does not specify quantified performance indicators, reporting targets, a comprehensive accountability framework, a formal implementation timetable or a budget.[3][10][4][5][9]

Monitoring & Evaluation

Monitoring and accountability arrangements centre on surveillance, phase-based actions, defined institutional responsibilities and post-event review. The plan uses the 2005 World Health Organization pandemic-phase framework and distinguishes measures according to whether influenza cases are occurring in Nauru.[2][3]The Nauru Pandemic Influenza Task Force is the principal coordinating body, chaired by the Director of Public Health, with the chair reporting meeting outcomes to the Minister for Health.[10][6]

• Review the plan annually through the Nauru Pandemic Influenza Task Force.[10]
• Conduct a debriefing after escalation to Phase 5 or above to assess operational effectiveness and social, economic and health effects, and use findings to update the plan.[10]
• Assign phase-linked activities to responsible authorities through Table 2, with requirements differentiated according to whether cases are present in Nauru.[3][10]
• Maintain task-force meetings monthly during lower phases, increase their frequency where necessary, and meet at least weekly in Phase 6.[10]
• Exchange surveillance and response information with the World Health Organization, Pacific Public Health Surveillance Network, PACNET, ProMED, other countries and relevant national agencies through electronic communication, telephone and meetings.[10]
• Make influenza-like illness reportable, detect cases through hospitals and communities, investigate cases and interview patients to identify possible infection sources.[4]
• Monitor absenteeism monthly during phases 4 to 6 and weekly during Phase 6, with the Director of Public Health receiving and analysing reports.[4]
• Monitor die-offs among birds, poultry and swine as potential animal-health signals.[4]
• Confirm suspected outbreaks through rapid testing, select specimens for reference testing, and send specimens to a level-2 reference laboratory for virus isolation, confirmation and strain subtyping.[4]
• Apply the surveillance definition of influenza-like illness: acute fever above 38°C with cough or sore throat and myalgia, without another diagnosis.[8]
• Monitor disease in influenza-affected households through community health nurses, and follow annexed procedures for specimen shipment and testing.[6][8]

Accountability is distributed across the Director of Public Health, Public Health Medical Officer, physicians, health inspectors, laboratories, quarantine officers, district committees, hospital staff, police, Immigration, Air Nauru and other public bodies.[4][5]The excerpts do not establish quantified performance indicators, surveillance thresholds or targets, standard reporting formats, a consolidated accountability framework, or evaluation methods beyond annual review and post-Phase-5 debriefing.[3][10][4][5][9][6][8]

Costing & Financing

The plan identifies substantial resource requirements for pandemic response but does not provide an overall budget, monetary costings, financing envelope, funding allocations, economic assumptions or quantified funding gap.[1][3][10][4][5][9][6][8]Resource constraints include limited initial availability of pandemic-specific vaccine, limited preventive and therapeutic measures, possible shortages of antibiotics for secondary bacterial infections, pressure on health services and potential workforce shortages affecting essential services.[7]

• Assess additional resources, interventions and emergency powers required for preparedness and response.[3][10]
• Secure further oseltamivir, antibiotics, vaccines, infection-control materials, specimen-shipment and testing capacity, expanded treatment facilities, mattresses and additional personnel.[4][9]
• Use 200 World Health Organization-provided courses of oseltamivir for priority services that must be maintained during a pandemic.[9][8]
• Prioritise essential-service personnel for scarce antiviral treatment and any future pandemic vaccine.[8]
• Seek foreign aid for additional medicines and supplies, as further antiviral procurement is expected to depend on external support.[9]
• Clarify funding for specimen shipment and whether the World Health Organization will meet freight and laboratory-testing charges.[4]
• Expand facilities and staffing where required, including through agreements for additional premises and mobilisation of supplementary personnel.[5][9]

The available antiviral stock is described as extremely limited, and a pandemic-specific vaccine may initially be unavailable or unobtainable in sufficient quantities for the full population.[8]Although procurement capacity and resource assessment are identified, the excerpts do not name domestic funding sources, set resource-mobilisation targets, allocate funds among agencies, specify donor commitments beyond the oseltamivir provision, or quantify the cost of planned activities.[3][10][4][9]